Aldeyra Therapeutics, Inc. (ALDX) Ownership

$5.74

north_east
$0.42 (7.9%)
Day's range
$5.28
Day's range
$5.75

Aldeyra Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
KNOLL CAPITAL MANAGEMENT, LLC 11/14/2025 5.48 M $28.58 M   0.00% 9.12%
PERCEPTIVE ADVISORS LLC 11/14/2025 5.22 M $27.26 M   28.89% 8.70%
BLACKROCK, INC. 11/12/2025 3.80 M $19.86 M   -1.22% 6.34%
VANGUARD GROUP INC 11/07/2025 3.59 M $18.75 M   2.58% 5.98%
ARDSLEY ADVISORY PARTNERS LP 11/14/2025 1.90 M $9.92 M   -7.32% 3.16%
AQR CAPITAL MANAGEMENT LLC 11/14/2025 1.51 M $7.86 M   2.14% 2.51%
D. E. SHAW & CO., INC. 11/14/2025 1.38 M $7.20 M   182.94% 2.30%
KINGDON CAPITAL MANAGEMENT, L.L.C. 11/14/2025 1.33 M $6.95 M   0.00% 2.22%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 1.18 M $6.14 M   2.60% 1.96%
KENNEDY CAPITAL MANAGEMENT LLC 11/13/2025 1.11 M $5.81 M   61.90% 1.85%
STATE STREET CORP 11/14/2025 1.10 M $5.76 M   4.36% 1.84%
MORGAN STANLEY 11/14/2025 1.08 M $5.65 M   39.78% 1.80%
JACOBS LEVY EQUITY MANAGEMENT, INC 11/17/2025 947.55 K $4.95 M   49.42% 1.58%
ACADIAN ASSET MANAGEMENT LLC 11/13/2025 835.81 K $4.36 M   334.41% 1.39%
683 CAPITAL MANAGEMENT, LLC 11/14/2025 820.00 K $4.28 M   -24.07% 1.37%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 648.37 K $3.38 M   -9.79% 1.08%
NORTHERN TRUST CORP 11/14/2025 407.96 K $2.13 M   0.99% 0.68%
BANK OF AMERICA CORP /DE/ 11/14/2025 390.08 K $2.04 M   590.51% 0.65%
WELLS FARGO & COMPANY/MN 11/13/2025 361.47 K $1.89 M   -0.74% 0.60%
DEUTSCHE BANK AG\ 11/13/2025 314.73 K $1.64 M   2.59% 0.52%
TWO SIGMA INVESTMENTS, LP 11/14/2025 273.05 K $1.43 M   389.88% 0.45%
WOODSTOCK CORP 10/07/2025 266.76 K $1.39 M   0.00% 0.44%
JANE STREET GROUP, LLC 11/14/2025 251.52 K $1.31 M   160.15% 0.42%
PALO ALTO INVESTORS LP 11/14/2025 225.47 K $1.18 M   0.00% 0.38%
UBS GROUP AG 11/13/2025 200.74 K $1.05 M   87.16% 0.33%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 197.30 K $1.03 M   74.91% 0.33%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2025 189.82 K $990.87 K   100.00% 0.32%
TWO SIGMA ADVISERS, LP 11/14/2025 184.10 K $961.00 K   497.73% 0.31%
GOLDMAN SACHS GROUP INC 11/14/2025 182.94 K $954.96 K   31.03% 0.30%
CITADEL ADVISORS LLC 11/14/2025 177.70 K $927.59 K   56.15% 0.30%
MARSHALL WACE, LLP 11/13/2025 160.21 K $836.31 K   100.00% 0.27%
IEQ CAPITAL, LLC 11/14/2025 159.15 K $830.78 K   8.38% 0.27%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 158.38 K $826.76 K   -31.66% 0.26%
CITADEL ADVISORS LLC 11/14/2025 152.25 K $794.77 K   1,122.53% 0.25%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 150.48 K $785.50 K   -4.48% 0.25%
MILLENNIUM MANAGEMENT LLC 11/14/2025 149.37 K $779.69 K   661.83% 0.25%
NUVEEN, LLC 11/12/2025 144.69 K $755.26 K   35.59% 0.24%
SAVANT CAPITAL, LLC 11/05/2025 144.06 K $752.00 K   -0.03% 0.24%
Y-INTERCEPT (HONG KONG) LTD 10/31/2025 138.09 K $720.84 K   100.00% 0.23%
INVESCO LTD. 11/13/2025 133.71 K $697.94 K   9.09% 0.22%
GSA CAPITAL PARTNERS LLP 11/07/2025 122.66 K $640.00 K   67.35% 0.20%
BANK OF NEW YORK MELLON CORP 11/03/2025 121.85 K $636.07 K   9.44% 0.20%
GROUP ONE TRADING, L.P. 11/12/2025 113.58 K $592.91 K   -14.59% 0.19%
RUSSELL INVESTMENTS GROUP, LTD. 11/13/2025 111.10 K $579.95 K   321.74% 0.19%
CUBIST SYSTEMATIC STRATEGIES, LLC 11/14/2025 101.38 K $529.18 K   238.29% 0.17%
STRS OHIO 10/30/2025 85.70 K $447.35 K   4.13% 0.14%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 81.00 K $422.82 K   -0.12% 0.13%
RHUMBLINE ADVISERS 11/06/2025 78.65 K $410.52 K   1.49% 0.13%
BARCLAYS PLC 11/12/2025 76.64 K $400.08 K   -19.87% 0.13%
ALLIANCEBERNSTEIN L.P. 11/14/2025 75.55 K $394.37 K   0.00% 0.13%

Aldeyra Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 174 institutional investors and hedge funds held shares of Aldeyra Therapeutics, Inc.. The most heavily invested institutionals were:

Knoll Capital Management, LLC: 5.48 M

PERCEPTIVE ADVISORS LLC: 5.22 M

BlackRock, Inc.: 3.8 M

VANGUARD GROUP INC: 3.59 M

ARDSLEY ADVISORY PARTNERS LP: 1.9 M

AQR CAPITAL MANAGEMENT LLC: 1.51 M

65.46% of Aldeyra Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 44.58 M shares in the last 24 months. This purchase volume represents approximately $255.91 M in transactions.